These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 34904919)

  • 21. Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma.
    Huang S; Chung JY; Li C; Wu Y; Qiao G; To KF; Tang PM
    Cancer Lett; 2024 Nov; 604():217272. PubMed ID: 39326553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.
    Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X
    Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.
    Shintani Y; Fujiwara A; Kimura T; Kawamura T; Funaki S; Minami M; Okumura M
    J Thorac Oncol; 2016 Sep; 11(9):1482-92. PubMed ID: 27287412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
    Peng Z; Ye M; Ding H; Feng Z; Hu K
    J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression.
    Chen H; Zhao L; Meng Y; Qian X; Fan Y; Zhang Q; Wang C; Lin F; Chen B; Xu L; Huang W; Chen J; Wang X
    Cancer Lett; 2022 Jun; 536():215611. PubMed ID: 35240233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer.
    Cords L; Engler S; Haberecker M; Rüschoff JH; Moch H; de Souza N; Bodenmiller B
    Cancer Cell; 2024 Mar; 42(3):396-412.e5. PubMed ID: 38242124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
    Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
    Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
    Chen S; Giannakou A; Wyman S; Gruzas J; Golas J; Zhong W; Loreth C; Sridharan L; Yamin TT; Damelin M; Geles KG
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11671-E11680. PubMed ID: 30487219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts.
    Lee PJ; Ho CC; Ho H; Chen WJ; Lin CH; Lai YH; Juan YC; Chu WC; Lee JH; Su SF; Chen HY; Chen JJW; Chang GC; Li KC; Yang PC; Chen HW
    Theranostics; 2021; 11(19):9667-9686. PubMed ID: 34646392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms.
    Hu H; Piotrowska Z; Hare PJ; Chen H; Mulvey HE; Mayfield A; Noeen S; Kattermann K; Greenberg M; Williams A; Riley AK; Wilson JJ; Mao YQ; Huang RP; Banwait MK; Ho J; Crowther GS; Hariri LP; Heist RS; Kodack DP; Pinello L; Shaw AT; Mino-Kenudson M; Hata AN; Sequist LV; Benes CH; Niederst MJ; Engelman JA
    Cancer Cell; 2021 Nov; 39(11):1531-1547.e10. PubMed ID: 34624218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Martinez-Zubiaurre I; Hellevik T
    Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell Transcriptomic Analysis Reveals an Immunosuppressive Network Between POSTN CAFs and ACKR1 ECs in TKI-resistant Lung Cancer.
    Wang Z; Yan N; Sheng H; Xiao Y; Sun J; Cao C
    Cancer Genomics Proteomics; 2024; 21(1):65-78. PubMed ID: 38151287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblast.
    Ochi K; Suzawa K; Thu YM; Takatsu F; Tsudaka S; Zhu Y; Nakata K; Takeda T; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Shien T; Okamoto Y; Tomida S; Toyooka S
    Cancer Sci; 2022 Oct; 113(10):3428-3436. PubMed ID: 35871750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression.
    Wu J; Liu X; Wu J; Lou C; Zhang Q; Chen H; Yang Z; Long S; Wang Y; Shang Z; Hu Z; Zhang R; Zhang J; Zeng Z
    Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166521. PubMed ID: 35985448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting CAFs to overcome anticancer therapeutic resistance.
    Saw PE; Chen J; Song E
    Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irradiated Tumor Fibroblasts Avoid Immune Recognition and Retain Immunosuppressive Functions Over Natural Killer Cells.
    Yang N; Lode K; Berzaghi R; Islam A; Martinez-Zubiaurre I; Hellevik T
    Front Immunol; 2020; 11():602530. PubMed ID: 33584669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.